Paysign, Inc.
Company Information
Industry
Services-Business Services, NEC
SIC Code
7389
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
2615 ST. ROSE PARKWAY, HENDERSON, NV, 89052
Mailing Address
2615 ST. ROSE PARKWAY, HENDERSON, NV, 89052
Phone
702-453-2221
Fiscal Year End
1231
EIN
954550154
Financial Overview
FY2025
$7.55M
Net Income
$227.76M
Total Liabilities
$48.49M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | March 26, 2026 | View on SEC |
| 10-K Annual financial report | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 24, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 12, 2025 | View on SEC |
| 4 Insider stock transaction report | September 26, 2025 | View on SEC |
| 4 Insider stock transaction report | September 26, 2025 | View on SEC |
| 4 Insider stock transaction report | September 26, 2025 | View on SEC |
Annual Reports
10-K
March 25, 2026
- Revenue grew 40.5% to $62.8 million, driven by a 167.8% surge in the pharmaceutical segment.
- Profitability nearly doubled year-over-year, rising from $3.8 million to $7.55 million.
Insider Trading
SELL
1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 7389)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.